EVMN logo

Evommune, Inc.

EVMN
Healthcare|Biotechnology|US
$6.65
+0.28 (+4.40%)
Tangible Book / Share
$7.68
Cash / Share
$5.56

Ownership Breakdown

54.8%
Float
36.3M
Shares Outstanding
19.9M
Float Shares

Major Holders (27)

Combined: 178.6%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
LSP 7 Management B.V.Other14.70%5,288,313Feb 19, 202613D/G
LSP 7 Cooperatieve U.A.Other14.70%5,288,313Feb 19, 202613D/G
Nan Fung Group Holdings LimitedCorporation10.90%3,435,599Feb 13, 202613D/G
NF Investment Holdings LimitedCorporation10.70%3,367,975Feb 13, 202613D/G
Nan Fung Life Sciences Holdings LimitedCorporation10.70%3,367,975Feb 13, 202613D/G
Rajeev ShahHC, IN9.70%3,494,638Feb 17, 202613D/G
Peter KolchinskyHC, IN9.70%3,494,638Feb 17, 202613D/G
RA Capital Management, L.P.IA, PN9.70%3,494,638Feb 17, 202613D/G
RA Capital Healthcare Fund, L.P.Partnership7.50%2,710,293Feb 17, 202613D/G
Pivotal Life Sciences Holdings LimitedCorporation6.10%1,926,943Feb 13, 202613D/G
Pivotal Partners LtdCorporation6.10%1,926,943Feb 13, 202613D/G
T. Rowe Price Associates, Inc.Investment adviser5.40%1,940,939Aug 14, 202613D/G
Point72 Asset Management, L.P.Partnership5.30%1,910,489Jul 16, 202613D/G
Steven A. CohenIndividual5.30%1,910,489Jul 16, 202613D/G
Point72 Capital Advisors, Inc.Corporation5.30%1,910,489Jul 16, 202613D/G
Pivotal bioVenture Partners Fund I U.G.P. Ltd.Corporation5.20%1,632,441Feb 13, 202613D/G
Pivotal bioVenture Partners Fund I G.P., L.P.Partnership5.20%1,632,441Feb 13, 202613D/G
Pivotal bioVenture Partners Fund I, L.P.Partnership5.20%1,632,441Feb 13, 202613D/G
NFLS Platform Holdings LimitedCorporation4.60%1,441,032Feb 13, 202613D/G
NFLS Delta III LimitedCorporation4.60%1,441,032Feb 13, 202613D/G
NFLS Delta LimitedCorporation4.60%1,441,032Feb 13, 202613D/G
BioDiscovery 6 FPCIOther3.90%1,391,990Aug 14, 202613D/G
Stephane BergezIndividual3.90%1,391,990Aug 14, 202613D/G
Francois Xavier MauronIndividual3.90%1,391,990Aug 14, 202613D/G
Andera PartnersOther3.90%1,391,990Aug 14, 202613D/G
Pivotal bioVenture Partners Fund II G.P. LtdCorporation0.90%294,502Feb 13, 202613D/G
Pivotal bioVenture Partners Fund II, L.P.Partnership0.90%294,502Feb 13, 202613D/G

Insider Trades (12)

InsiderPositionDateTypeSharesPriceValueFiling
Pena Luis C.director, officer: President & CEOSep 30, 2026AWARD1,115$7.02$7.8KForm 4
Carver KyleChief Financial OfficerJul 8, 2026BUY1,000$13.26$13.3KForm 4
KIRSCH ARTHUR SdirectorJul 7, 2026BUY10,000$13.30$133.0KForm 4
Drew Janice SuzannChief of Dev. OperationsJun 22, 2026OPTION EX.16,161$2.99$48.3KForm 4
Drew Janice SuzannChief of Dev. OperationsJun 22, 2026OPTION EX.3,839$3.84$14.7KForm 4
Drew Janice SuzannChief of Dev. OperationsJun 22, 2026SELL20,000$22.63$452.6KForm 4
Drew Janice SuzannChief of Dev. OperationsJun 22, 2026OPTION EX.3,839$3.84$14.7KForm 4
Drew Janice SuzannChief of Dev. OperationsJun 22, 2026OPTION EX.16,161$2.99$48.3KForm 4
Patel Jeegar PravinkumarChief Scientific OfficerJun 22, 2026OPTION EX.1,488$3.84$5.7KForm 4
Patel Jeegar PravinkumarChief Scientific OfficerJun 22, 2026SELL1,488$22.50$33.5KForm 4
Patel Jeegar PravinkumarChief Scientific OfficerJun 22, 2026OPTION EX.1,488$3.84$5.7KForm 4
Pena Luis C.director, officer: President & CEOJun 22, 2026SELL7,438$22.71$168.9KForm 4